Bariatric surgery is more cost-effective and offers better long-term outcomes than GLP-1 RAs for obesity and metabolic comorbidities. GLP-1 RAs face challenges like high costs, limited insurance ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite recent price reductions, GLP-1 weight loss ...

Some people’s first thoughts may have been about which celebrities are taking weight loss drugs, but if you’re struggling with weight gain or worried about cardiovascular health conditions, your first ...

With a background in journalism and counseling, Penny Min blends analytical research with real-world insight to help readers make informed financial decisions. At Forbes Marketplace, she specializes ...

Whether and how to cover GLP-1 medications for weight loss is a challenging issue for many employers. As obesity rates remain high in many states, employers are making tough decisions about whether ...

Some patients shared they were excited to get bariatric surgery when Act 628 became law, only to get hit with $25k ...